EUVIMED · CrossrefJournal
Respiratory Research
ISSN 1465-993X · Springer Science and Business Media LLC
Latest articles
Mucin expression and mucus obstruction varies with small airway size in COPD
Predictors and prevalence of symptoms suggestive of dysfunctional breathing four years after COVID-19: a prospective observational study
From ex vivo personalized theratyping to in vivo validation: unmasking next-generation vanzacaftor-tezacaftor efficacy in the ETI-resistant H147P-CFTR variant
Association between bosutinib treatment and pulmonary arterial hypertension in patients with chronic myeloid leukaemia
Effects of endoscopic lung volume reduction on the rib cage and inspiratory intercostal muscles
Higher versus lower PEEP during non-invasive ventilation to stabilize preterm infants within their SpO2 target: a prospective real-life randomized cross-over trial
Bone morphogenetic protein 4 protects mice from bleomycin-induced pulmonary injury, inflammation and fibrosis
Anti-IL-4Rα antibody attenuates hypochlorous acid-induced systemic sclerosis-related interstitial lung disease and inhibits profibrotic macrophages
Severe asthma across the adult lifespan: age-stratified outcome trajectories from the swiss severe asthma registry
Long-term air pollution exposure and incident asthma risk in Chinese middle-aged and older adults: a national prospective cohort study with mechanistic insights
Longitudinal evaluation of the one-minute sit-to-stand test in fibrosing interstitial lung diseases: association with the six-minute walk test and patient outcomes
S100A8 is associated with transitional epithelial dysfunction in sepsis-induced acute lung injury
High-flow nasal cannula compared with non-invasive ventilation for acute hypercapnic respiratory failure in patients with acute exacerbations of COPD: a systematic review and meta-analysis of comparative studies
Burden and clinical characteristics of respiratory syncytial virus infection in older adults in the outpatient setting in Germany: a prospective multiseason study
Global burden of chronic obstructive pulmonary disease attributable to air pollution among older adults from Global Burden of Disease 2021
Comorbidity between respiratory system diseases and atherosclerosis: mechanisms and potential treatments
Integrative multi-omics analysis identifies molecular signatures associated with high-risk of systemic reactions to honeybee venom and olive pollen
Inhaled vs. intravenous sedation in moderate-to-severe acute respiratory distress syndrome: a meta-analysis of randomized controlled trials
Dihydroartemisinin alleviates allergic airway inflammation by suppressing the PI3K-AKT signaling axis: integrated network pharmacology and experimental validation
CISD1 suppresses COPD inflammation by recruiting ubiquitinated STING and altering macrophage metabolism
Nebulized nintedanib (AP02) for idiopathic pulmonary fibrosis demonstrates favorable safety and lung lining fluid exposures: results from two phase I safety, tolerability, and pharmacokinetics studies
Endoplasmic reticulum stress promotes ferroptosis in ventilator-induced lung injury by promoting HRD1-dependent GPX4 ubiquitination via the IRE1α/XBP1 pathway
Respiratory outcomes in Korean COPD patients using e-cigarettes: methodological and interpretive limitations
Response to “Respiratory outcomes in Korean COPD patients using e-cigarettes: methodological and interpretive limitations”
T cell exhaustion in the peripheral blood of patients with sporadic lymphangioleiomyomatosis
Single-cell immune profiling and machine learning reveal a predictive immune signature for immunotherapy response in NSCLC
Elarekibep, an inhaled Anticalin protein, targets IL-4Rα locally: first-in-human randomized phase 1 trials of a novel potential therapeutic class in asthma
The risk and economic burden of interstitial lung disease in patients with non-small cell lung cancer treated with immune checkpoint inhibitors and targeted therapies
Timing of antifibrotic therapy and prognosis in idiopathic pulmonary fibrosis: real-world evidence from the French Colibri-ILD SNDS database
Maxing Loushi Decoction alleviates COPD by targeting the PD-1/PD-L1 pathway: restoring Th17/Treg balance and inhibiting ferroptosis
EUVIMED